Meilleure Health International Industry Group Limited provided preliminary consolidated earnings guidance for the year ended 31 December 2023. Based on the preliminary review of the unaudited consolidated management accounts of the Group for the year ended 31 December 2023 and the information currently available to the Company, the Group expects to record a profit attributable to the Shareholders in the range of approximately HKD 38 million to HKD 43.8 million for the year ended 31 December 2023 as compared to a profit attributable to the Shareholders of approximately HKD 17.8 million for the year ended 31 December 2022.